Involvement of FHIT in lung carcinogenesis prospects for future clinical gene therapy applications
Sozzi, G.; Andriani, F.; Gramegna, M.; Roz, L.
I Suppli di Tumori Official Journal of Societa Italiana di Cancerologia . 1(4): S62
2002
ISSN/ISBN: 2283-5423 PMID: 12415825 Document Number: 542127
Document emailed within 1 workday
Related Documents
Sozzi, G.; Tornielli, S.; Tagliabue, E.; Sard, L.; Pezzella, F.; Pastorino, U.; Minoletti, F.; Pilotti, S.; Ratcliffe, C.; Veronese, M.L.; Goldstraw, P.; Huebner, K.; Croce, C.M.; Pierotti, M.A. 1997: Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities Cancer Research 57(23): 5207-5212Byrnes, A.P. 2005: Challenges and future prospects in gene therapy Idrugs: the Investigational Drugs Journal 8(12): 993-996
Blum, A. 2002: Volumic and multislice CT: principles, applications and future prospects Jbr-Btr: Organe de la Societe Royale Belge de Radiologie 85(2): 82-99
Rosenecker, J.; Huth, S.; Rudolph, C. 2006: Gene therapy for cystic fibrosis lung disease: current status and future perspectives Current Opinion in Molecular Therapeutics 8(5): 439-445
Runge, D.M.; Runge, D. 1995: Somatic gene therapy. Initial clinical applications and current research approach Fortschritte der Medizin 113(24): 337-340
Garrod, L.P. 1970: Clinical applications of trimethoprim-sulphamethoxazole: achievements and prospects South African Medical Journal 44(32 Suppl): 12-14
Pathak, A.K.; Bhutani, M.; Mohan, A.; Guleria, R.; Bal, S.; Kochupillai, V. 2004: Non small cell lung cancer (NSCLC): current status and future prospects Indian Journal of Chest Diseases and Allied Sciences 46(3): 191-203
Thiagalingam, S.; Lisitsyn, N.A.; Hamaguchi, M.; Wigler, M.H.; Willson, J.K.; Markowitz, S.D.; Leach, F.S.; Kinzler, K.W.; Vogelstein, B. 1996: Evaluation of the FHIT gene in colorectal cancers Cancer Research 56(13): 2936-2939
Kaneda, Y.; Morishita, R. 1997: Development of in vivo gene transfer methods towards future gene therapy Rinsho Byori. Japanese Journal of Clinical Pathology 45(2): 99-105
Negrini, M.; Monaco, C.; Vorechovsky, I.; Ohta, M.; Druck, T.; Baffa, R.; Huebner, K.; Croce, C.M. 1996: The FHIT gene at 3p14.2 is abnormal in breast carcinomas Cancer Research 56(14): 3173-3179
Liu, F.; Wu, J.; Sun, Y. 2003: FHIT gene is abnormal in tongue carcinoma cell line Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20(3): 472-475
Cohen-Haguenauer, O.; Boiron, M. 1992: Gene therapy: facts and prospects Pathologie-Biologie 40(1): 5-13
Hozumi, M. 1998: Differentiation therapy of leukemia: achievements, limitations and future prospects International Journal of Hematology 68(2): 107-129
Cairella, M.; Volpari, B. 1971: Therapy with organ transplants: current possibilities and future prospects. Ii La Clinica Terapeutica 57(3): 249-284
Eady, E.A.; Cove, J.H. 1990: Topical antibiotic therapy: current status and future prospects Drugs under Experimental and Clinical Research 16(8): 423-433
Sonoo, H. 2007: Current status and future prospects for breast cancer therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 6: 391-395
Schipeleva, I.A.; Markovskaya, E.I. 2016: Plague Antibacterial Therapy. Historical Aspects and Future Prospects Antibiotiki i Khimioterapiia 61(9-10): 74-80
Turyk, S. 2000: Applications of gene therapy in medical genetics Medicina 60(1): 26-28
Wang, X.W.; Harris, C.C. 1996: TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy Cancer Surveys 28: 169-196
Wilson, J.M.; Chowdhury, J.R. 1990: Prospects for gene therapy of familial hypercholesterolemia Molecular Biology and Medicine 7(3): 223-232